← Open Payments lookup

JESSICA SCHMALZ: Open Payments

NPI 1538754064 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$750 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $624 · 2025 $750

Food & beverage: $638Education: $111
CompanyPaymentsAmount
Alkermes, Inc.8$219
Teva Pharmaceuticals USA, Inc.3$143
E.R. Squibb & Sons, L.L.C.3$140
Vanda Pharmaceuticals Inc.4$92
Neurocrine BioSciences, Inc.2$39
Janssen Pharmaceuticals, Inc2$32
Axsome Therapeutics, Inc.1$32
Lundbeck LLC1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
ABBVIE INC.1$15

Products named: ARISTADA, COBENFY, FANAPT, INGREZZA, INVEGA SUSTENNA, Auvelity, AUSTEDO XR, REXULTI.

Industry payments across CO — which companies pay providers there.